Avanir Pharmaceuticals Inc - Company & Market Research Reports

Avanir Pharmaceuticals focuses on the research, development and commercialization of novel medical and pharmaceutical treatments for people with central nervous system disorders. It primarily offers NUEDEXTA, a dual N-methyl-D-aspartate receptor antagonist and sigma-1 agonist for the treatment of pseudobulbar affect; and Docosanol 10% cream, an over-the-counter product for the treatment of cold sores. Avanir Pharmaceuticals was founded in 1988 and is headquartered in Aliso Viejo, California.

From
From
Alzheimer's Disease - Pipeline Review, H2 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2018

  • Drug Pipelines
  • 1333 Pages
From
Schizophrenia - Pipeline Review, H2 2018 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H2 2018

  • Drug Pipelines
  • 321 Pages
From
From
Schizophrenia - Pipeline Review, H1 2018 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H1 2018

  • Drug Pipelines
  • 334 Pages
From
Depression - Pipeline Review, H2 2018 - Product Thumbnail Image

Depression - Pipeline Review, H2 2018

  • Drug Pipelines
  • 504 Pages
From
From
From
Depression - Pipeline Review, H1 2018 - Product Thumbnail Image

Depression - Pipeline Review, H1 2018

  • Drug Pipelines
  • 490 Pages
From
From
From
From
From
From
From
From
Migraine - Pipeline Review, H2 2018 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2018

  • Drug Pipelines
  • 231 Pages
From
Dyskinesia - Pipeline Review, H2 2018 - Product Thumbnail Image

Dyskinesia - Pipeline Review, H2 2018

  • Drug Pipelines
  • 182 Pages
From
Loading Indicator
adroll